Zimmer Biomet (ZBH) PT Raised to $125 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $97.31 +0.95%
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 22 | New: 16
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 22 | New: 16
Join SI Premium – FREE
JPMorgan analyst Robbie Marcus raised the price target on Zimmer Biomet (NYSE: ZBH) to $125.00 (from $115.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Exlservice (EXLS) PT Raised to $48 at Stifel
- C.H. Robinson Worldwide (CHRW) PT Lowered to $198 at Stifel
- Alphabet (GOOGL) PT Lowered to $332 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
